.. .. Le-but-de-notre-Étude,

.. .. Notre-Étude,

. .. Abstract,

. Matériels and . .. Méthodes,

. .. Résultats,

. .. Discussion,

. .. Limites-de-l'étude,

. .. Conclusion,

.. .. Bibliographie-de-l'étude,

.. .. Conclusions,

I. )-réduction-du-nombre-de-traitements and .. .. , 65 a. Pourquoi essayer de diminuer le taux de thérapies inappropriées et appropriées, p.65

. , Comment les diminuer ?

. Ii)-le and .. .. Dai-sous-cutané,

G. Pochmalicki, L. Tarnec, J. Franchi, J. Empana, J. Genest et al., Management of sudden death in a semi-rural district, the DEFI 77 study, vol.100, pp.838-882, 2007.

D. P. Zipes and H. J. Wellens, Sudden cardiac death, Circulation, vol.24, issue.21, pp.2334-51, 1998.

E. Jaillette, C. Girault, G. Brunin, F. Zerimech, A. Chiche et al., French Intensive Care Society, International congress-Réanimation, Ann Intensive Care. juin, vol.6, issue.1, p.50, 2016.

A. K. Bilge, B. Ozben, S. Demircan, M. Cinar, E. Yilmaz et al., Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors, Pacing Clin Electrophysiol PACE. juin, vol.29, issue.6, pp.619-645, 2006.

S. F. Sears, L. Sowell, E. A. Kuhl, A. H. Kovacs, E. R. Serber et al., The ICD shock and stress management program: a randomized trial of psychosocial treatment to optimize quality of life in ICD patients, Pacing Clin Electrophysiol PACE. juill, vol.30, issue.7, pp.858-64, 2007.

A. J. Moss, C. Schuger, C. A. Beck, M. W. Brown, D. S. Cannom et al., Reduction in inappropriate therapy and mortality through ICD programming, N Engl J Med. 13 déc, vol.367, issue.24, pp.2275-83, 2012.

D. Costa, A. Kirkorian, G. Cucherat, M. Delahaye, F. Chevalier et al., Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis, Circulation. 12 mai, vol.97, issue.18, pp.1796-801, 1998.

G. Habib, P. Lancellotti, M. J. Antunes, M. G. Bongiorni, J. Casalta et al., ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM), Eur Heart J, vol.36, issue.44, pp.3075-128, 2015.

N. Shariff, E. Eby, E. Adelstein, S. Jain, A. Shalaby et al., Health and Economic Outcomes Associated with Use of an Antimicrobial Envelope as a Standard of Care for Cardiac Implantable Electronic Device Implantation, J Cardiovasc Electrophysiol. juill, vol.26, issue.7, pp.783-792, 2015.

S. Madan, P. Muthusamy, K. L. Mowers, D. A. Elmouchi, B. Finta et al., Safety of anticoagulation with uninterrupted warfarin vs. interrupted dabigatran in patients requiring an implantable cardiac device, Cardiovasc Diagn Ther. févr, vol.6, issue.1, pp.3-9, 2016.

C. Romeyer-bouchard, D. Costa, A. Abdellaoui, L. Messier, M. Thévenin et al., Simplified cardiac resynchronization implantation technique involving right access and a triple-guide/single introducer approach, Heart Rhythm Off J Heart Rhythm Soc. juill, vol.2, issue.7, pp.714-723, 2005.

A. Ghani, P. Delnoy, R. Misier, A. R. Smit, J. Adiyaman et al., Incidence of lead dislodgement, malfunction and perforation during the first year following device implantation, Neth Heart J Mon J Neth Soc Cardiol Neth Heart Found. juin, vol.22, issue.6, pp.286-91, 2014.

E. S. Barin, S. M. Jones, D. E. Ward, A. J. Camm, and A. W. Nathan, The right ventricular outflow tract as an alternative permanent pacing site: long-term follow-up, Pacing Clin Electrophysiol PACE. janv, vol.14, issue.1, pp.3-6, 1991.

L. Liu, J. Tang, H. Peng, S. Wu, C. Lin et al., A long-term, prospective, cohort study on the performance of right ventricular pacing leads: comparison of active-fixation with passive-fixation leads, Sci Rep, vol.5, p.7662, 2015.

A. Schuchert, H. Van-langen, K. Michels, and T. Meinertz,

A. J. Moss, W. J. Hall, D. S. Cannom, J. P. Daubert, S. L. Higgins et al., Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators, N Engl J Med. 26 déc, vol.335, issue.26, pp.1933-1973, 1996.

S. J. Connolly, M. Gent, R. S. Roberts, P. Dorian, D. Roy et al., Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone, Circulation. 21 mars, vol.101, issue.11, pp.1297-302, 2000.

P. Ponikowski, A. A. Voors, S. D. Anker, H. Bueno, J. Cleland et al., ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC), Eur J Heart Fail. 20 mai, 2016.

G. H. Bardy, K. L. Lee, D. B. Mark, J. E. Poole, D. L. Packer et al., Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure, N Engl J Med. 20 janv, vol.352, issue.3, pp.225-262, 2005.

A. E. Buxton, K. L. Lee, J. D. Fisher, M. E. Josephson, E. N. Prystowsky et al., A randomized study of the prevention of sudden death in patients with coronary artery disease

, Multicenter Unsustained Tachycardia Trial Investigators, N Engl J Med. 16 déc, vol.341, issue.25, pp.1882-90, 1999.

M. R. Bristow, L. A. Saxon, J. Boehmer, S. Krueger, D. A. Kass et al., Cardiacresynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure, N Engl J Med. 20 mai, vol.350, issue.21, pp.2140-50, 2004.

A. Kadish, A. Dyer, J. P. Daubert, R. Quigg, N. Estes et al., Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy, N Engl J Med. 20 mai, vol.350, issue.21, pp.2151-2159, 2004.

A. J. Moss, W. Zareba, W. J. Hall, H. Klein, D. J. Wilber et al., Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction, N Engl J Med. 21 mars, vol.346, issue.12, pp.877-83, 2002.

K. B. Lewis, D. Stacey, S. L. Carroll, L. Boland, L. Sikora et al., Estimating the Risks and Benefits of Implantable Cardioverter Defibrillator Generator Replacement: A Systematic Review, Pacing Clin Electrophysiol PACE. juill, vol.39, issue.7, pp.709-731, 2016.

M. S. Ascoeta, E. Marijon, P. Defaye, D. Klug, F. Beganton et al., Impact of early complications on outcomes in patients with implantable cardioverter-defibrillator for primary prevention, Heart Rhythm Off J Heart Rhythm Soc. mai, vol.13, issue.5, pp.1045-51, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01272165

J. Kron, J. Herre, E. G. Renfroe, C. Rizo-patron, M. Raitt et al., Lead-and device-related complications in the antiarrhythmics versus implantable defibrillators trial, Am Heart J. janv, vol.141, issue.1, pp.92-100, 2001.

C. Borleffs, L. Van-erven, R. J. Van-bommel, E. T. Van-der-velde, E. E. Van-der-wall et al., Risk of failure of transvenous implantable cardioverter-defibrillator leads, Circ Arrhythm Electrophysiol. août, vol.2, issue.4, pp.411-417, 2009.

M. Lunati, A. Proclemer, G. Boriani, M. Landolina, E. Locati et al., Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database, Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 29 janv, 2016.

O. Nordkamp, L. Postema, P. G. Knops, R. E. Van-dijk, N. Limpens et al., Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications, Heart Rhythm Off J Heart Rhythm Soc. févr, vol.13, issue.2, pp.443-54, 2016.

S. F. Sears, L. Sowell, E. A. Kuhl, A. H. Kovacs, E. R. Serber et al., The ICD shock and stress management program: a randomized trial of psychosocial treatment to optimize quality of life in ICD patients, Pacing Clin Electrophysiol PACE. juill, vol.30, issue.7, pp.556-62, 2007.

A. J. Moss, C. Schuger, C. A. Beck, M. W. Brown, D. S. Cannom et al., Reduction in inappropriate therapy and mortality through ICD programming, N Engl J Med. 13 déc, vol.367, issue.24, pp.2275-83, 2012.

P. Palmisano, M. Accogli, M. Zaccaria, G. Luzzi, F. Nacci et al., Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol, Eur Soc Cardiol. avr, vol.15, issue.4, pp.531-571, 2013.

E. Marijon, L. Trinquart, A. Otmani, X. Waintraub, S. Kacet et al., Bigger JT. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators, Am Heart J. févr, vol.157, issue.2, pp.1569-75, 1997.

G. Boriani, E. Berti, L. Belotti, M. Biffi, D. Palma et al., Cardiac device therapy in patients with left ventricular dysfunction and heart failure: « real-world » data on long-term outcomes (mortality, hospitalizations, days alive and out of hospital), Eur J Heart Fail. juin, vol.18, issue.6, pp.693-702, 2016.

D. S. Lee, J. V. Tu, P. C. Austin, P. Dorian, Y. R. Chong et al., Effect of cardiac and noncardiac conditions on survival after defibrillator implantation, J Am Coll Cardiol. 26 juin, vol.49, issue.25, pp.2408-2423, 2007.

J. J. Germano, M. Reynolds, V. Essebag, and M. E. Josephson, Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic?, Am J Cardiol. 15 avr, vol.97, issue.8, pp.1255-61, 2006.

Y. Konstantino, T. Shafat, V. Novack, L. Novack, and G. Amit, Incidence of Implantable Cardioverter Defibrillator Therapy and Mortality in Primary and Secondary Prevention of Sudden Cardiac Death, Isr Med Assoc J IMAJ. déc, vol.17, issue.12, pp.760-763, 2015.

S. Boulé, M. Sémichon, L. Guédon-moreau, É. Drumez, C. Kouakam et al.,

, Long-term outcome of implantable cardioverter-defibrillator implantation in secondary prevention of sudden cardiac death. Arch Cardiovasc Dis

G. H. Disponible-sur-;-van-welsenes, J. B. Van-rees, C. Borleffs, S. C. Cannegieter, J. J. Bax et al., Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card, Cell Electrophysiol Eur Soc Cardiol. mars, vol.13, issue.3, pp.389-94, 2011.

D. Yung, D. Birnie, P. Dorian, J. S. Healey, C. S. Simpson et al., Survival after implantable cardioverter-defibrillator implantation in the elderly, Circulation. 18 juin, vol.127, issue.24, pp.2383-92, 2013.

L. Fauchier, E. Marijon, P. Defaye, O. Piot, N. Sadoul et al., Effect of age on survival and causes of death after primary prevention implantable cardioverter-defibrillator implantation, Am J Cardiol. 15 mai, vol.115, issue.10, pp.1415-1437, 2015.

V. H. Tan, S. B. Wilton, V. Kuriachan, G. L. Sumner, and D. V. Exner, Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis, Circ Arrhythm Electrophysiol. févr, vol.7, issue.1, pp.164-70, 2014.

B. L. Wilkoff, K. T. Ousdigian, L. D. Sterns, Z. J. Wang, R. D. Wilson et al., A comparison of empiric to physician-tailored programming of implantable cardioverterdefibrillators: results from the prospective randomized multicenter EMPIRIC trial, J Am Coll Cardiol. 18 juill, vol.48, issue.2, pp.330-339, 2006.

P. A. Scott, J. Silberbauer, T. A. Mcdonagh, and F. D. Murgatroyd, Impact of prolonged implantable cardioverter-defibrillator arrhythmia detection times on outcomes: a metaanalysis, Heart Rhythm Off J Heart Rhythm Soc. mai, vol.11, issue.5, pp.828-863, 2014.

, Bibliographies des conclusions et perspectives

A. J. Moss, W. J. Hall, D. S. Cannom, J. P. Daubert, S. L. Higgins et al., Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators, N Engl J Med. 26 déc, vol.335, issue.26, pp.1933-1973, 1996.

A. J. Moss, W. Zareba, W. J. Hall, H. Klein, D. J. Wilber et al., Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction, N Engl J Med. 21 mars, vol.346, issue.12, pp.877-83, 2002.

G. H. Bardy, K. L. Lee, D. B. Mark, J. E. Poole, D. L. Packer et al., Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure, N Engl J Med. 20 janv, vol.352, issue.3, pp.225-262, 2005.

T. Smith, D. Theuns, K. Caliskan, and L. Jordaens, Long-term follow-up of prophylactic implantable cardioverter-defibrillator-only therapy: comparison of ischemic and nonischemic heart disease, Clin Cardiol. déc, vol.34, issue.12, pp.761-768, 2011.

G. H. Van-welsenes, J. B. Van-rees, C. Borleffs, S. C. Cannegieter, J. J. Bax et al., Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol, Eur Soc Cardiol. mars, vol.13, issue.3, pp.389-94, 2011.

J. B. Van-rees, C. Borleffs, M. K. De-bie, T. Stijnen, L. Van-erven et al., Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality, J Am Coll Cardiol. 1 févr, vol.57, issue.5, pp.556-62, 2011.

J. J. Germano, M. Reynolds, V. Essebag, and M. E. Josephson, Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic?, Am J Cardiol. 15 avr, vol.97, issue.8, pp.1255-61, 2006.

G. Habib, P. Lancellotti, M. J. Antunes, M. G. Bongiorni, J. Casalta et al., , 2015.

, ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC), Eur Heart J, vol.36, issue.44, pp.3075-128, 2015.

A. K. Bilge, B. Ozben, S. Demircan, M. Cinar, E. Yilmaz et al., Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors, Pacing Clin Electrophysiol PACE. juin, vol.29, issue.6, pp.619-645, 2006.

A. Ruwald, C. Schuger, A. J. Moss, V. Kutyifa, B. Olshansky et al., Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT), Circ Arrhythm Electrophysiol, vol.7, issue.5, pp.785-92, 2014.

J. E. Poole, G. W. Johnson, A. S. Hellkamp, J. Anderson, D. J. Callans et al., Prognostic importance of defibrillator shocks in patients with heart failure, N Engl J Med, vol.359, issue.10, pp.1009-1026, 2008.

M. Lunati, A. Proclemer, G. Boriani, M. Landolina, E. Locati et al., Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database, Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 29 janv, 2016.

P. Kirchhof, S. Benussi, D. Kotecha, A. Ahlsson, D. Atar et al., ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC)Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESCEndorsed by the European Stroke Organisation (ESO). Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card, Cell Electrophysiol Eur Soc Cardiol. 27 août, 2016.

B. De-piccoli, F. Rigo, A. Raviele, E. Piccolo, C. Maggiolo et al.,

, Transesophageal echocardiographic evaluation of the morphologic and hemodynamic cardiac changes during ventricular fibrillation, J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. févr, vol.9, issue.1, pp.71-79, 1996.

M. Runsiö, L. Bergfeldt, L. A. Brodin, A. Ribeiro, S. Samuelsson et al., Left ventricular function after repeated episodes of ventricular fibrillation and defibrillation assessed by transoesophageal echocardiography, Eur Heart J. janv, vol.18, issue.1, pp.124-155, 1997.

J. Poelaert, L. Jordaens, C. A. Visser, D. Clerck, C. Herregods et al., Transoesophageal echocardiographic evaluation of ventricular function during transvenous defibrillator implantation, Acta Anaesthesiol Scand. sept, vol.40, issue.8, pp.913-921, 1996.

T. M. Hurst, M. Hinrichs, C. Breidenbach, N. Katz, and B. Waldecker, Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators, J Am Coll Cardiol. août, vol.34, issue.2, pp.402-410, 1999.

M. Saeed, I. Hanna, D. Robotis, R. Styperek, L. Polosajian et al., Programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock: results from the PROVIDE study, J Cardiovasc Electrophysiol. janv, vol.25, issue.1, pp.52-61, 2014.

N. Clementy, B. Pierre, B. Lallemand, O. Marie, E. Lemoine et al., Long-term follow-up on high-rate cut-off programming for implantable cardioverter defibrillators in primary prevention patients with left ventricular systolic dysfunction. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol, juill, vol.14, issue.7, pp.968-74, 2012.

T. A. Dewland, C. N. Pellegrini, Y. Wang, G. M. Marcus, E. Keung et al., Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverterdefibrillator registry, J Am Coll Cardiol. 30 août, vol.58, issue.10, pp.1007-1020, 2011.

B. L. Wilkoff, B. D. Williamson, R. S. Stern, S. L. Moore, F. Lu et al., Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study, J Am Coll Cardiol. 12 août, vol.52, issue.7, pp.541-50, 2008.

A. J. Moss, C. Schuger, C. A. Beck, M. W. Brown, D. S. Cannom et al., Reduction in inappropriate therapy and mortality through ICD programming, N Engl J Med. 13 déc, vol.367, issue.24, pp.2275-83, 2012.

M. Gasparini, A. Proclemer, C. Klersy, A. Kloppe, M. Lunati et al., Effect of long-detection interval vs standard-detection interval for implantable cardioverterdefibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial, JAMA. 8 mai, vol.309, issue.18, pp.1903-1914, 2013.

P. Ritter, G. Z. Duray, C. Steinwender, K. Soejima, R. Omar et al., Early performance of a miniaturized leadless cardiac pacemaker: the Micra Transcatheter Pacing Study, Eur Heart J, vol.36, issue.37, pp.2510-2519, 2015.

F. Tjong, T. F. Brouwer, L. Smeding, K. M. Kooiman, J. R. De-groot et al., Combined leadless pacemaker and subcutaneous implantable defibrillator therapy: feasibility, safety, and performance. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card, Cell Electrophysiol Eur Soc Cardiol. 3 mars, 2016.